Ampio Pharmaceuticals Inc Stock News
$0.241
+0.0155 (+6.89%)
At Close: May 07, 2024
Ampio Pharmaceuticals Is Waking Up From Its COVID-19 Slumber, Approaching Potential Approval For Severe OAK (NYSEMKT:AMPE)
07:37pm, Wednesday, 16'th Sep 2020
Ampio’s delayed pivotal phase 3 trial for severe OAK to resume. Strong hints of Ampion showing efficacy in COVID-19.
Glistering Stock: Ampio Pharmaceuticals, Inc. (AMPE), Facebook, Inc. (FB) - Stocks Equity
11:55pm, Friday, 28'th Aug 2020
Ampio Pharmaceuticals, Inc. (AMEX:AMPE) with the stream of 6.80% also noticed, India Facebook, Inc. (NASDAQ:FB) encountered a rapid change of 0.15% in the last hour of Friday’s trading session. Ampi
Ampio Provides Update on COVID-19 Clinical Trial Activities
12:00pm, Wednesday, 19'th Aug 2020
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, provides updates regardin
7 Penny Stocks Worth the Danger as Pandemic Catalyzes Growth
06:43pm, Friday, 31'st Jul 2020
Investing in penny stocks is primarily the domain of highly risk-averse market participants. The risk profile of penny stocks is, of course, a double-edged sword: investors could lose a lot of money o
Ampio Starts Patient Enrollment in its Ampion COVID-19 Program
12:00pm, Thursday, 23'rd Jul 2020
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio"), is a biopharmaceutical company focused on the development and advancement of immunology-based therapies for prevalent infl
Mid-Morning Market Update: Markets Down; AT&T Earnings Beat Estimates
12:00am, Thursday, 23'rd Jul 2020
Following the market opening Thursday, the Dow traded down 0.26% to 26,936.51 while the NASDAQ fell 0.11% to 10,692.02. The S&P also fell, dropping 0.04% to 3,274.73.
The U.S...
Ampio Reports a Publication on the Potential Benefits of Ampion for Treatment of a New COVID-19 related Syndrome
12:00pm, Monday, 20'th Jul 2020
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the development and advancement of immunology based therapies for prevalent inflammatory conditions, today ann
Outlook of Diabetic Macular Edema (DME) 2020-2025 - Current Landscape and the Way Forward - ResearchAndMarkets.com
12:00am, Monday, 13'th Jul 2020
The
2020 Study into the Global Macular Edema Industry - Market Size and Drug Sales - ResearchAndMarkets.com
12:00am, Thursday, 02'nd Jul 2020
The
Ampio Pharmaceuticals (AMPE) Jumps: Stock Rises 8.7%
03:31pm, Monday, 29'th Jun 2020
Ampio Pharmaceuticals (AMPE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
-$0.04 Earnings Per Share Expected for Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) This Quarter
12:04pm, Monday, 29'th Jun 2020
Wall Street brokerages expect Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) to post earnings of ($0.04) per share for the current quarter, according to Zacks. Zero analysts have issued estimates for Ampio
Regeneron's Latest Approval, And Other News: The Good, Bad And Ugly Of Biopharma
02:54pm, Monday, 22'nd Jun 2020
Regeneron's dupixent gets an approval. AbbVie walks out of Assembly Biosciences partnership. Ampio will begin a COVID-19 trial.
Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Shares Gap Up to $0.57
02:49am, Sunday, 21'st Jun 2020
Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) gapped up prior to trading on Friday . The stock had previously closed at $0.33, but opened at $0.57. Ampio Pharmaceuticals shares last traded at $0.57, w
Italy sewage study suggests COVID-19 was there in December 2019 Scientists in Italy have found traces of the new coronavirus in wastewater collected from Milan and Turin in December 2019 - suggesting
